Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2026, Radiopharm Theranostics had annual revenue of 12.63M AUD with 0.97% growth. Radiopharm Theranostics had revenue of 6.20M in the half year ending December 31, 2025, with 52.60% growth.

• Revenue (ttm): 12.63M AUD
• Revenue Growth: +0.97%
• P/S Ratio: 3.20
• Revenue / Employee: 902,436 AUD
• Employees: 14
• Market Cap: 28.01M USD

Revenue Chart

Chart

Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	12.63M	121.93K	0.97%
Jun 30, 2025	12.51M	10.55M	538.86%
Jun 30, 2024	1.96M	-4.25M	-68.46%
Jun 30, 2023	6.21M	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 29, 2026

Data Sources Report a data error